🌟 Exciting News! 🌟 We are excited to announce our participation at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid! 🧠💡 Our very own Laura Breda will represent Cilcare, bringing forward our cutting-edge work in hearing disorders and their connection to neurodegenerative diseases. Recent findings, such as the association between self-reported hearing loss and faster cognitive and functional decline in the ADNI cohort, and the impact of comorbid conditions on the progression from Mild Cognitive Impairment to Dementia, emphasize the critical role that hearing health plays in neurodegenerative diseases like Alzheimer’s. At Cilcare, we are proud to be at the forefront of exploring these connections and contributing to solutions that could impact patients' lives. Stay tuned for insights from this important event, and feel free to reach out if you'd like to connect in Madrid! #CTAD2024 #Neuroscience #Alzheimers #HearingHealth #Innovation #ClinicalTrials #hearingloss #tinnitus
Cilcare
Recherche en biotechnologie
Montpellier, Languedoc-Roussillon 4 505 abonnés
MAKING HEARING A PRIORITY
À propos
CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.
- Site web
-
http://www.cilcare.com
Lien externe pour Cilcare
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 11-50 employés
- Siège social
- Montpellier, Languedoc-Roussillon
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2014
- Domaines
- hearing disorders, tinnitus, hearing loss, pharmaceutical development, pharmacology, clinical development, preclinical development, GLP ototoxicology, hearing loss, tinnitus, auditory safety, ear disorders, AI et precision medicine
Lieux
-
Principal
378 rue du Professeur Joseph-Blayac
34080 Montpellier, Languedoc-Roussillon, FR
-
500 Shire Way
02421 Lexington, Massachusetts, US
Employés chez Cilcare
-
Hatim Bekkali
Fondateur, BizDev chez SYLOÉ , Groupe DRI.FR
-
Celia Belline
CEO - Cilcare #biotech #BPI Excellence #hearingloss #AI #synaptopathy #tinnitus #CCE #TFE #MedVallee Ambassador - Montpellier | Boston | Paris
-
Sandrine BADOUARD
Finance manager
-
Dona M.P. Jayakody, PhD, FICDA
Head-Brain and Hearing at Ear Science Institute Australia
Nouvelles
-
🚀 Envie d'avancer concrètement vers plus d'impact dans vos projets ? Le 10 octobre à #Montpellier, Susanna Malmström interviendra aux côtés d’autres grands experts pour vous faire passer de l'Impact Score à l'Action. 🌍 Un rendez-vous incontournable pour transformer vos ambitions en actions concrètes. Au programme : des partages d'expériences et des clés pratiques pour faire la différence. 🗣️ Aux côtés de Christelle Siddi, Laurent Milesi, Halima SADIKI, Adrien Conty, Morgane Le Breton, Anthony Lecossois 📦🌱, Pierre-Edouard Robert, nous vous partagerons les meilleures outils pour progresser vers un impact durable et réel. 📅 Jeudi 10 octobre 2024, de 13h30 à 19h00 📍 @La Cité de l’Économie et des Métiers de Demain 🔗https://lnkd.in/ekpwpdu4 Mouvement Impact France, Montpellier Méditerranée Métropole, La Région Occitanie / Pyrénées-Méditerranée, Entreprendre à Montpellier, AD'OCC', Agence de Développement et des Transitions Ne manquez pas cette occasion d'accélérer votre démarche d'impact ! #impact #développementdurable #événement
-
🌏 We are thrilled to announce our participation at Bio Japan 2024! Join us in Yokohama from October 9th to 11th as our CEO, Celia Belline, represents Cilcare at this prestigious event. Japan plays a key role in Cilcare's journey, particularly through our ongoing collaboration with Shionogi & Co., Ltd to develop innovative compounds targeting cochlear synaptopathy. This partnership underscores Japan’s importance as a hub for cutting-edge research in hearing loss and inner ear disorders. At Bio Japan, we look forward to exploring new collaborations and showcase our breakthrough developments, such as CIL001 drug candidate. Looking forward to connecting with partners and experts from around the world to make hearing a priority ! #BioJapan2024 #Biotechnology #HearingHealthcare #Innovation #Collaboration #hearingloss #tinnitus
-
We are delighted to welcome Patricia Machado as our new Early Drug Development & Pipeline Director! With an impressive background in neuroscience and over 13 years of experience at leading pharmaceutical companies like Pfizer and Servier Pharmaceuticals, Patricia brings invaluable expertise to our mission of advancing breakthrough treatments for hearing disorders. Her strategic leadership will be key in driving our innovative drug pipeline forward, including the development of CIL001, a first-in-class treatment for cochlear synaptopathy. Patricia’s appointment further strengthens our commitment to addressing the growing global need for hearing disorder solutions, with more than 2.5 billion people expected to suffer from hearing loss by 2050. We are thrilled to have Patricia on board as we continue to push boundaries and make a lasting impact on hearing healthcare worldwide. Join us in celebrating this exciting new chapter for Cilcare! 🎉 Link to the full Press Release available in the comment. #NewAppointment #Biotech #HearingHealthcare #DrugDevelopment #Leadership #HearingInnovation #hearingloss #tinnitus
-
🌍 World Deaf Day 2024: A Call for Innovation and Action in Hearing Health 🎧 Tomorrow, on World Deaf Day, we reflect on the importance of raising awareness about hearing loss and advancing solutions for millions of people affected globally. Recent studies highlight an alarming rise in hearing loss, with more than 140 million cases globally in 2019—a staggering 93.89% increase since 1990. This surge reflects not only population growth but also the aging demographic, with hearing loss increasingly impacting the elderly and leading to serious consequences like postural instability and increased fall risks. At Cilcare, we recognize the urgency of this issue. By 2040, hearing loss cases are projected to rise even further, with significant health inequalities across regions. Now, more than ever, targeted and innovative solutions are needed to address this growing burden. Our work with CIL001 and other breakthrough therapies is aimed at providing the world with effective treatments that not only restore hearing but also enhance quality of life, for both young people at high risk of hearing impairment and our aging population. As we mark World Deaf Day tomorrow, let’s amplify the call for prevention, early diagnosis, and effective management to tackle the challenges of hearing loss. #WorldDeafDay2024 #HearingLossAwareness #PublicHealth #AgingPopulation #HearingInnovation Reference : Global, regional, and national prevalence of hearing loss from 1990 to 2019: A trend and health inequality analyses based on the Global Burden of Disease Study 2019, Ageing Res Rev, 2023
-
🎉 WCA Paris 2024 Wrap-Up – The Audiology Olympics! 🎉 The World Congress of Audiology 2024 in Paris felt like the Olympic Games of audiology, as described by Audiologie Demain! With 3,800 professionals, 112 nations, and 600 world-renowned experts, it was an event to remember. As Dr. Hung THAI-VAN emphasized, the ambition to lead in global audiology is evident, with the increasing visibility of French audiologists' scientific and clinical contributions showcasing the dynamism of the community. 💡 At Cilcare, we are proud to be at the forefront, driving the future of hearing healthcare. Some major highlights: 🔍 Hidden hearing loss, a recently recognized yet challenging condition, continues to be a therapeutic hurdle. At Cilcare, we are advancing solutions with our lead compound CIL001 to address the root causes. In France, our unique approach to hearing care integrates ENT specialists, audioprosthetists, and speech therapists. With the growing availability of advanced detection tools and the rise of digital hearing tests offered by ENTs, audioprosthetists, and even at home, opportunities are emerging to improve the detection and management of hidden hearing loss conditions. 📊 CAFPAS (Common Audiological Functional Parameters), derived from extensive patient data, are being enhanced with machine learning predictions. We also see a growing trend toward automating testing and reducing bias, with calls for a "salami slicing" approach to tailor treatments for specific subpopulations using AI and biomarkers. At Cilcare, we are enhancing this approach with digital auditory signatures, allowing for personalized diagnostics and treatment strategies tailored to individual patient needs. 🧠 The ACHIEVE study, lead by Frank Lin underscores the critical role of hearing care in mental health, revealing that proper management of hearing health can slow cognitive decline by up to 48%. 👶 Gene therapy advances with the successful treatment of the first patient in Australia in Sensorion’s Audiogene study, offering hope to babies born deaf due to OTOF gene mutations. 🔔 And the quest to treat tinnitus with diverse solutions is gaining momentum, while sadly, hearing loss still lacks effective treatment options. WCA Paris 2024 was an incredible display of innovation, passion, and collaboration, and we are excited to be part of this global movement to transform the future of hearing health. Jean-Hugues Masgnaux Naimi M. Gaelle Naert Mathieu Schue Sylvie Pucheu Véronique B. Susanna Malmström Patricia Machado Marie Peytavy-Izard Mary Audu Hugo Vanacker Jérome Geoffroy #WCA2024 #HearingHealth #Audiology #Innovation #HearingLoss #CognitiveHealth #Tinnitus #GeneTherapy #MachineLearning
-
🚀 We’re hiring ! Join our team as an Office Coordinator in Cilcare USA! Cilcare, a biotech specialized in auditory science, is seeking a highly organized and proactive Office Coordinator to support the US team. If you're skilled in both administrative and financial tasks, we'd love to meet you! 🔍 Key Responsibilities: 🔹 Employee Support: Assist with taxes, benefits, compliance, and housing. 🔹Financial Admin: Manage purchase orders, track invoices, maintain records. 🔹HR Support: Help with onboarding, training, and SOP updates. 🔹Coordination: Schedule meetings and arrange travel for staff. 🎯 Qualifications: 🔹Bachelor’s degree or equivalent. 🔹2 years in finance or admin. 🔹Strong multitasking, time management, and interpersonal skills. 🔹Proficient in Microsoft Office and fluent in English. 💼 Location: Lexington, MA Interested? Visit https://lnkd.in/eVrxWsjn for the full job offer and apply! #Hiring #OfficeCoordinator #AdminSupport #FinanceAdmin #JoinOurTeam
-
🚨 Join us at the World Congress of Audiology! 🎧 Stop by our booth#43 level D to meet our experts and explore: 🔹 Our pipeline of drug candidates with opportunities of licensing & co-development 🔹 Ototoxicity assessments 🔹 Latest clinical research on diabetes and hearing loss and much more ! Gaelle Naert Mathieu Schue Susanna Malmström Sylvie Pucheu Mary Audu Patricia Machado Naimi M. Hugo Vanacker Jérome Geoffroy Jean-Hugues Masgnaux Véronique B. Marie Peytavy-Izard #Audiology #HearingCare #Ototoxicity #HearingLoss #Innovation #WorldCongressAudiology #HearingHealth #HealthcareResearch
-
🎉 What an incredible experience at the Inner Ear Biology Workshop in Warsaw! 🎉 Cilcare is proud to have been part of such a remarkable event, where we showcased our latest advancements in auditory science and preclinical research. A special mention to Marion Souchal and Marianne Aincy, who delivered insightful oral presentations and represented Cilcare’s research during the poster session. A warm thank you to Professor Prof. Piotr H. Skarżyński, General Secretary of the 59th IEB Workshop, for the organization of this fantastic event as well as everyone who attended our presentations. 🙏 Gaelle Naert, Sylvie Pucheu and Cilcare’s scientific team are excited about the insights gained and collaborations formed. Together, we’ll continue pushing the boundaries of hearing innovation. 🌍🎧 #HearingResearch #AuditoryScience #Innovation #IEB2024 #HearingHealth #Ototoxicity #PreclinicalModels
-
Our CEO had the honor of speaking alongside Jean-Marc Oluski, President of MEDEF Montpellier Hérault, and Michaël Delafosse, Mayor of Montpellier, to present the important work of the Medef Hérault Health Commission. She highlighted that the development of health innovations relies on the collaboration of all stakeholders in the healthcare ecosystem, particularly those working directly with patients. Their involvement is crucial to driving meaningful advancements in the sector. Réseau Medef Hérault Montpellier MedVallée Montpellier
CEO - Cilcare #biotech #BPI Excellence #hearingloss #AI #synaptopathy #tinnitus #CCE #TFE #MedVallee Ambassador - Montpellier | Boston | Paris
Quelques bonnes nouvelles des CCE Occitanie dans la lettre M pour débuter la #REFMontpellier 2024 avec Françoise Nauton-Inglis nommée Présidente de Digital113 et Mathilde Boulachin qui explose à l’international🙂 Ouverture de la scène avec une session “on se dit tout” entre Jean-Marc Oluski et Michaël Delafosse L’occasion de rappeler les responsabilités de chacun dans le développement économique du territoire et la necessité de travailler ensemble dans un contexte politique « plastique ». Au sein de la commission santé 🏥 qui rassemble tous les acteurs de la chaine de valeurs des entreprises de santé du Réseau Medef Hérault Montpellier on traite les problèmes à la source et on se focalise d’abord sur des points essentiels : « 👩⚕️👨⚕️pas de santé sans soignants, pas d’innovation santé sans soignants non plus ». Dans un contexte où les abandons en 2 eme année d’écoles d’infirmiers sont sans précédents, il nous paraît essentiel de contribuer à connecter le monde des entreprises de la santé aux soignants pour leur rappeler qu’ils jouent un rôle essentiel dans le développement des innovations santé de demain 🙏 Les patients ont besoin de vous, les innovations aussi et les entreprises du Réseau Medef Hérault Montpellier se mobilisent pour vous l’exprimer. Fédération de l'Hospitalisation Privée (FHP) Agence Régionale de Santé Occitanie (ARS) Université de Montpellier Cilcare MedVallée Montpellier